Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC

IF 13.3 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Cardiovascular Research Pub Date : 2025-03-14 DOI:10.1093/cvr/cvaf023
Sean M Davidson, Ioanna Andreadou, Charalambos Antoniades, Jozef Bartunek, Cristina Basso, Bianca J J M Brundel, Robert A Byrne, Gemma Chiva-Blanch, Paula da Costa Martins, Paul C Evans, Henrique Girão, Zoltan Giricz, Can Gollmann-Tepeköylü, Tomasz Guzik, Mariann Gyöngyösi, Norbert Hübner, Michael Joner, Petra Kleinbongard, Thomas Krieg, Elisa Liehn, Rosalinda Madonna, Ange Maguy, Melanie Paillard, Maurizio Pesce, Steffen E Petersen, Gabriele G Schiattarella, Joost P G Sluijter, Sabine Steffens, Katrin Streckfuss-Bömeke, Matthias Thielmann, Art Tucker, Sophie Van Linthout, William Wijns, Johann Wojta, Joseph C Wu, Cinzia Perrino
{"title":"Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC","authors":"Sean M Davidson, Ioanna Andreadou, Charalambos Antoniades, Jozef Bartunek, Cristina Basso, Bianca J J M Brundel, Robert A Byrne, Gemma Chiva-Blanch, Paula da Costa Martins, Paul C Evans, Henrique Girão, Zoltan Giricz, Can Gollmann-Tepeköylü, Tomasz Guzik, Mariann Gyöngyösi, Norbert Hübner, Michael Joner, Petra Kleinbongard, Thomas Krieg, Elisa Liehn, Rosalinda Madonna, Ange Maguy, Melanie Paillard, Maurizio Pesce, Steffen E Petersen, Gabriele G Schiattarella, Joost P G Sluijter, Sabine Steffens, Katrin Streckfuss-Bömeke, Matthias Thielmann, Art Tucker, Sophie Van Linthout, William Wijns, Johann Wojta, Joseph C Wu, Cinzia Perrino","doi":"10.1093/cvr/cvaf023","DOIUrl":null,"url":null,"abstract":"Animal models offer invaluable insights into disease mechanisms but cannot entirely mimic the variability and heterogeneity of human populations, nor the increasing prevalence of multi-morbidity. Consequently, employing human samples—such as whole blood or fractions, valvular and vascular tissues, myocardium, pericardium, or human-derived cells—is essential for enhancing the translational relevance of cardiovascular research. For instance, myocardial tissue slices, which preserve crucial structural and functional characteristics of the human heart, can be used in vitro to examine drug responses. Human blood serves as a rich source of biomarkers, including extracellular vesicles, various types of RNA (miRNA, lncRNA, and circRNAs), circulating inflammatory cells, and endothelial colony-forming cells, facilitating detailed studies of cardiovascular diseases. Primary cardiomyocytes and vascular cells isolated from human tissues are invaluable for mechanistic investigations in vitro. In cases where these are unavailable, human induced pluripotent stem cells serve as effective substitutes, albeit with specific limitations. However, the use of human samples presents challenges such as ethical approvals, tissue procurement and storage, variability in patient genetics and treatment regimens, and the selection of appropriate control samples. Biobanks are central to the efficient use of these scarce and valuable resources. This scientific statement discusses opportunities to implement the use of human samples for cardiovascular research within specific clinical contexts, offers a practical framework for acquiring and utilizing different human materials, and presents examples of human sample applications for specific cardiovascular diseases, providing a valuable resource for clinicians, translational and basic scientists engaged in cardiovascular research.","PeriodicalId":9638,"journal":{"name":"Cardiovascular Research","volume":"8 1","pages":""},"PeriodicalIF":13.3000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cvr/cvaf023","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Animal models offer invaluable insights into disease mechanisms but cannot entirely mimic the variability and heterogeneity of human populations, nor the increasing prevalence of multi-morbidity. Consequently, employing human samples—such as whole blood or fractions, valvular and vascular tissues, myocardium, pericardium, or human-derived cells—is essential for enhancing the translational relevance of cardiovascular research. For instance, myocardial tissue slices, which preserve crucial structural and functional characteristics of the human heart, can be used in vitro to examine drug responses. Human blood serves as a rich source of biomarkers, including extracellular vesicles, various types of RNA (miRNA, lncRNA, and circRNAs), circulating inflammatory cells, and endothelial colony-forming cells, facilitating detailed studies of cardiovascular diseases. Primary cardiomyocytes and vascular cells isolated from human tissues are invaluable for mechanistic investigations in vitro. In cases where these are unavailable, human induced pluripotent stem cells serve as effective substitutes, albeit with specific limitations. However, the use of human samples presents challenges such as ethical approvals, tissue procurement and storage, variability in patient genetics and treatment regimens, and the selection of appropriate control samples. Biobanks are central to the efficient use of these scarce and valuable resources. This scientific statement discusses opportunities to implement the use of human samples for cardiovascular research within specific clinical contexts, offers a practical framework for acquiring and utilizing different human materials, and presents examples of human sample applications for specific cardiovascular diseases, providing a valuable resource for clinicians, translational and basic scientists engaged in cardiovascular research.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在转译心血管研究中使用人类样本的机遇和挑战:ESC心脏细胞生物学工作组、ESC心血管外科工作组、ESC基础心血管科学委员会、ESC明日科学家、ESC欧洲经皮心血管干预协会和ESC心力衰竭协会的科学声明
动物模型为疾病机制提供了宝贵的见解,但不能完全模拟人类群体的变异性和异质性,也不能模拟多重发病的日益流行。因此,使用人类样本——如全血或部分血、瓣膜和血管组织、心肌、心包或人源性细胞——对于增强心血管研究的转化相关性至关重要。例如,心肌组织切片保存了人类心脏的关键结构和功能特征,可以在体外用于检查药物反应。人体血液是生物标志物的丰富来源,包括细胞外囊泡、各种类型的RNA (miRNA、lncRNA和circrna)、循环炎症细胞和内皮集落形成细胞,有助于心血管疾病的详细研究。从人体组织中分离的原代心肌细胞和血管细胞对于体外机制研究是非常宝贵的。在无法获得这些干细胞的情况下,人类诱导多能干细胞可以作为有效的替代品,尽管有特定的限制。然而,人类样本的使用面临着诸如伦理审批、组织采购和储存、患者遗传学和治疗方案的可变性以及选择适当的对照样本等挑战。生物银行是有效利用这些稀缺和宝贵资源的核心。本科学声明讨论了在特定临床背景下实施心血管研究中使用人类样本的机会,提供了获取和利用不同人类材料的实用框架,并介绍了特定心血管疾病的人类样本应用示例,为从事心血管研究的临床医生、转化和基础科学家提供了宝贵的资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardiovascular Research
Cardiovascular Research 医学-心血管系统
CiteScore
21.50
自引率
3.70%
发文量
547
审稿时长
1 months
期刊介绍: Cardiovascular Research Journal Overview: International journal of the European Society of Cardiology Focuses on basic and translational research in cardiology and cardiovascular biology Aims to enhance insight into cardiovascular disease mechanisms and innovation prospects Submission Criteria: Welcomes papers covering molecular, sub-cellular, cellular, organ, and organism levels Accepts clinical proof-of-concept and translational studies Manuscripts expected to provide significant contribution to cardiovascular biology and diseases
期刊最新文献
miR-146a-5p mediates atherogenic signalling from immune to vascular cells. Telomere recapping prevents pathogenic telomere-to-mitochondrial DNA communication in heart failure Withholding beta-blockers after myocardial infarction: reasons to be cautious. Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients. Bridging the mind-heart gap: depression in CVD clinical practice guidelines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1